Gerald Muench is a senior faculty in the discipline of Pharmacology and has been working as Founder Chair, Pharmacology Department, UWS School of Medicine, University of Western Sydney.
Gerald Muench (born on 24 March 1961) is an Australian-German medical scientist; who started his career in 1995 from the University of Würzburg, Germany. He was then appointed a teaching post in the Department of Child and Adolescent Psychiatry in 1999. In 2000, he joined the Interdisciplinary Centre for Clinical Research at the University of Leipzig, which he left in 2004 to take up a position as senior lecturer at James Cook University in Townsville. In May 2008, he was appointed as associate professor of pharmacology in the UWS School of Medicine, University of Western Sydney (now Western Sydney University). [1]
He has worked on various projects such as of Western Sydney University, National Health and Medical Research Council, Commonwealth Scientific and Industrial Research Organisation, J.O. & J.R. Wicking Foundation, Alzheimer's Australia, GeroNova Research, Inc, Palo Alto (USA), Alteon Inc., Parsippany (USA), Eurochem Feinchemie, (Munich, Germany). [2]
He belongs to family lineage of Münch
He has served on the editorial boards of many international scientific journals and has been a consultant with Aventis, Roche Diagnostics, Merz, ASTA Medica/Degussa and Geronova. At present, he is a member of editorial board for the Journal of Neural Transmission. [4]
Western Sydney University, formerly the University of Western Sydney, is an Australian multi-campus university in the Greater Western region of Sydney, Australia. The university in its current form was founded in 1989 as a federated network university with an amalgamation between the Nepean College of Advanced Education and the Hawkesbury Agricultural College. The Macarthur Institute of Higher Education was incorporated in the university in 1989. In 2001, the University of Western Sydney was restructured as a single multi-campus university rather than as a federation. In 2015, the university underwent a rebranding which resulted in a change in name from the University of Western Sydney to Western Sydney University. It is a provider of undergraduate, postgraduate, and higher research degrees with campuses in Bankstown, Blacktown, Campbelltown, Hawkesbury, Liverpool, Parramatta, and Penrith.
Advanced glycation end products (AGEs) are proteins or lipids that become glycated as a result of exposure to sugars. They are a bio-marker implicated in aging and the development, or worsening, of many degenerative diseases, such as diabetes, atherosclerosis, chronic kidney disease, and Alzheimer's disease.
Peter Riederer is a German neuroscientist with several thousands of citations and around 950 scientific writings. He has published more than 620 scientific papers in peer-reviewed scientific journals that are indexed in Medline. He has been author and co-author of more than 20 books relevant to the fields of neuroscience, psychiatry and neurology.
Matthias Werner Hentze is a German scientist. He is the Director of the European Molecular Biology Laboratory (EMBL) and Professor of Molecular Medicine at Heidelberg University.
Robert Hodge is an Australian academic, author, theorist and critic. While best known as a semiotician and critical linguist, his work encompasses a wide, interdisciplinary range of fields including cultural theory, media studies, chaos theory, Marxism, psychoanalysis, post-colonialism, post-modernism and many other topics both within the humanities as well as science. He is currently a professor at the University of Western Sydney.
Enzo Emanuele is an Italian clinical pathologist known for his interdisciplinary research in the field of biological psychology. He has studied the biochemical basis of romantic interpersonal attraction and identified the neurotrophin nerve growth factor (NGF) as a key biochemical mediator of falling in love. The implications of this research have been criticized in the popular press. In 2008, his genetic research, which showed an association between serotonin and dopamine receptor gene polymorphisms and certain love traits, was awarded with the International Zdenek Klein Award for Human Ethology from the Charles University in Prague, Czech Republic.
Stefanie Dimmeler is a German biologist specializing in the pathophysiological processes underlying cardiovascular diseases. Her awards and honours include the Gottfried Wilhelm Leibniz Prize of the German Research Foundation for her work on the programmed cell death of endothelial cells. Since 2008 she has led the Institute for Cardiovascular Regeneration at the University of Frankfurt. Her current work is focusing to develop cellular and pharmacological strategies to improve cardiovascular repair and regeneration. Her work aims to establish non-coding RNAs as novel therapeutic targets.
Graham Leon Collingridge is a British neuroscientist and professor at the University of Toronto and at the University of Bristol. He is also a senior investigator at the Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital in Toronto.
Ragbir BhathalFRSN, FRAS, FSAAS is an Australian astronomer and author, currently based at the Western Sydney University (WSU), Australia. He is known for his work on Optical Search for Extra-Terrestrial Intelligence (OSETI). He did his Ph.D. in magnetism at the University of Queensland. He has served as a UNESCO consultant on science policy for the ASEAN group of nations, as an Adviser to the Federal Minister for Science and was the Project Director for the million dollar Sydney Observatory restoration building program. Bhathal also designed and built the twin dome Campbelltown Rotary Observatory at the WSU Campbelltown Campus and was Patron of Macarthur Astronomical Society from 1997 to 2011.
Moussa B. H. Youdim born in Teheran Iran, is an Israeli neuroscientist interested in neurochemistry and neuropharmacology. He is the discoverer of monoamine oxidase (MAO) B inhibitors l-deprenyl (selegiline) and rasagiline (Azilect) as anti-Parkinson drugs. He is currently Professor Emeritus at Technion-Faculty of Medicine and President of Youdim Pharmaceuticals.
Ulrike Müßig is a German jurist and legal historian as well as Head of the Chair for Civil Law, German and European Legal History at the University of Passau.
Suh Yoo-hun is a South Korean neuroscientist. His researches focus on neurodegeneration, especially on the discovery of genes and therapies for Alzheimer's disease and Parkinson's disease.
Josephine Forbes is an Australian scientist specialising in the study of glycation and diabetes. She has been studying diabetes since 1999 and has worked at Royal Children's Hospital, University of Melbourne and Baker Heart and Diabetes Institute in Melbourne Australia. Since 2012 she has led the Glycation and Diabetes team at Mater Research which is a world-class medical research institute based at South Brisbane, and part of the Mater Group. Josephine is program leader for Mater's Chronic Disease Biology and Care theme, building greater understanding of the biological basis of a broad range of chronic diseases, and developing preventative strategies and innovative treatments to improve patient outcomes. Josephine and her team focus on how advanced glycation contributes to the pathogenesis of diabetes and its complications such as kidney disease.
Argpyrimidine is an organic compound with the chemical formula C11H18N4O3. It is an advanced glycation end-product formed from arginine and methylglyoxal through the Maillard reaction. Argpyrimidine has been studied for its food chemistry purposes and its potential involvement in aging diseases and Diabetes Mellius.
Katja Becker is a German physician and biochemist who has been serving as the president of the German Research Foundation (DFG since 2020. She had previously been the organization's vice president from 2014-2019.
Rohini Kuner is an Indian-born German pharmacologist and director of the Institute of Pharmacology at Heidelberg University.
Kochupurackal P. Mohanakumar is an Indian chemical biologist, neuroscientist and the director of Inter University Centre for Biomedical Research and Super Specialty Hospital, Kottayam. He is a former chief scientist at the Indian Institute of Chemical Biology and is known for his studies on Parkinson's disease and Huntington’s disease. The Department of Biotechnology of the Government of India awarded him the National Bioscience Award for Career Development, one of the highest Indian science awards, for his contributions to biosciences in 2000.
Colin Louis MastersMD is an Australian neuropathologist who researches Alzheimer's disease and other neurodegenerative disorders. He is laureate professor of pathology at the University of Melbourne.
Georg Peters was a German physician, microbiologist and university professor. From 1992 until his fatal mountain accident he headed the Institute of Medical Microbiology at the University of Münster. He was an internationally recognised expert in the field of staphylococci and the infectious diseases caused by them, to which he had devoted himself since the beginning of his scientific career.
T Govindaraju is a Professor in the Bioorganic Chemistry Laboratory at Jawaharlal Nehru Centre for Advanced Scientific Research, Bengaluru. The researchers in the Bioorganic Chemistry Laboratory work in areas which lie at the intersection of chemistry, biology and biomaterials science, and in particular, on problems related to Alzheimer's disease, peptide chemistry, molecular probes, molecular architectonics, nanoarchitectonics and biomimetics.